NASDAQ : TEM
Tempus AI, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 72.22 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 13.03B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 14.16B |
| Enterprise Value | 14.74B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 175.39M |
| Shares Outstanding | 180.43M |
| Shares Change (YoY) | +4.75% |
| Shares Change (QoQ) | -0.60% |
| Owned by Insiders (%) | 28.92% |
| Owned by Institutions (%) | 56.67% |
| Float | 123.35M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.74 |
| Forward PS | 7.84 |
| PB Ratio | 26.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 10.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.61 |
| Quick Ratio | 2.33 |
| Debt / Equity | 2.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.99 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -37.55% |
| Return on Assets (ROA) | -7.38% |
| Return on Invested Capital (ROIC) | -9.25% |
| Return on Capital Employed (ROCE) | -13.86% |
| Weighted Average Cost of Capital (WACC) | 21.85% |
| Revenue Per Employee | $397,197 |
| Profits Per Employee | -$49,814 |
| Employee Count | 3,800 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 9.86 |
Taxes
| Measure | Value |
|---|
| Income Tax | -5.71M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 3.54 |
| 52-Week Price Change | -12.65% |
| 50-Day Moving Average | 70.80 |
| 200-Day Moving Average | 56.99 |
| Relative Strength Index (RSI) | 58.60 |
| Average Volume (20 Days) | 6,920,205 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 25.38M |
| Short Previous Month | 25.12M |
| Short % of Shares Out | 14.06% |
| Short % of Float | 20.57% |
| Short Ratio (days to cover) | 3.32 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.51B |
| Gross Profit | 972.95M |
| Operating Income | -279.32M |
| Pretax Income | -195.00M |
| Net Income | -189.29M |
| EBITDA | -193.36M |
| EBIT | -279.32M |
| Loss Per Share | -$1.06 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 637.35M |
| Total Debt | 1.43B |
| Net Cash | -582.28M |
| Net Cash Per Share | -$3.23 |
| Equity (Book Value) | 500.40M |
| Book Value Per Share | 2.75 |
| Working Capital | 700.47M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -108.37M |
| Capital Expenditures | -28.42M |
| Depreciation & Amortization | 85.96M |
| Net Borrowing | 128.98M |
| Free Cash Flow | -136.79M |
| FCF Per Share | -$0.76 |
Margins
| Measure | Value |
|---|
| Gross Margin | 64.46% |
| Operating Margin | -18.51% |
| Pretax Margin | -12.92% |
| Profit Margin | -12.54% |
| EBITDA Margin | -12.81% |
| EBIT Margin | -18.51% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.75% |
| Shareholder Yield | -4.75% |
| Earnings Yield | -1.35% |
| FCF Yield | -0.93% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $77.67 |
| Price Target Difference | -1.03% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (3Y) | 23.22% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |